4.24 USD
↘ 0.10 (2.19%)LIVE (AS OF 02:42 PM EDT)
Rezolute, Inc. Common Stock (NV)
RZLTNASDAQ • USD
Market: OPEN
Rezolute, Inc. Common Stock (NV) (RZLT) is currently trading at $4.24. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place RZLT at a fair price relative to peers.
Technical & fundamental data as of Oct 5, 2026.
Open?$4.64
High?$4.64
Low?$4.16
Prev. Close?$4.33
Volume?1.3M
Avg. Volume?1.5M
VWAP?$4.36
Rel. Volume?0.83x
Bid / Ask
Bid?$4.24 × 1.3K
Ask?$4.25 × 500
Spread?$0.01
Midpoint?$4.25
Valuation & Ratios
Market Cap?418.8M
Shares Out?96.7M
Float?82.3M
Float %?85.5%
P/E Ratio?N/A
P/B Ratio?4.16
EPS?-$0.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Employees
58
Market Cap
418.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2011-12-23
Address
275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY, CA 94065
Phone: 650-206-4507
REDWOOD CITY, CA 94065
Phone: 650-206-4507
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?13.32Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?20.43%Squeeze Risk
Short Interest?16.8M
Days to Cover?14.8
Free Float82.3M
Avg Daily Volume1.1M
Settlement Date2026-09-15
Financial Health
Current Ratio?9.68Strong
Quick Ratio?9.68Strong
Cash Ratio?0.93Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.16FAIR▾
Peers100
S&P43
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-77.1%WEAK▾
S&P3
ROA?-68.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-64635000
Enterprise Value?$408.2M
Fundamentals ratios updated end of day